Molecular biology of drug resistance in Mycobacterium tuberculosis

Current Topics in Microbiology and Immunology

Volumn 374, Issue , 2013, Pages 53-80

  Smith, Tasha ^a   Wolff, Kerstin A ^a   Nguyen, Liem ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CHEMICAL MODIFICATION; DRUG CHOICE; DRUG POTENCY; DRUG TARGETING; DRUG TOLERANCE; ENZYME DEGRADATION; EPIGENETICS; GENE MUTATION; HOMEOSTASIS; HUMAN; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT DURATION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION; GENES, MDR; GENETIC FITNESS; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PYRAZINAMIDE; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84892698163     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2012-279     Document Type: Article

References (134)

1. Adams KN, Takaki K, Connolly LE et al (2011) Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39-53
2. Ainsa JA, Blokpoel MC, Otal I, Young DB, De Smet KA, Martin C (1998) Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in mycobacterium fortuitum and mycobacterium tuberculosis. J Bacteriol 180:5836-5843
3. Ainsa JA, Martin C, Gicquel B, Gomez-Lus R (1996) Characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase gene from mycobacterium fortuitum. Antimicrob Agents Chemother 40:2350-2355
4. Aldridge BB, Fernandez-Suarez M, Heller D, Ambravaneswaran V, Irimia D, Toner M, Fortune SM (2012) Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335:100-104
5. Alekshun MN, Levy SB (1997) Regulation of chromosomally mediated multiple antibiotic resistance: The mar regulon. Antimicrob Agents Chemother 41:2067-2075
6. Andersson DI (2006) The biological cost of mutational antibiotic resistance: Any practical conclusions? Curr Opin Microbiol 9:461-465
7. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: Is it possible to reverse resistance? Nature reviews. Microbiology 8:260-271
8. Andersson DI, Levin BR (1999) The biological cost of antibiotic resistance. Curr Opin Microbiol 2:489-493
9. Andini N, Nash KA (2006) Intrinsic macrolide resistance of the mycobacterium tuberculosis complex is inducible. Antimicrob Agents Chemother 50:2560-2562
10. Andriole VT (2005) The quinolones: Past, present, and future. Clin Infect Dis 41(Suppl 2):S113-S119
11. Bamaga M, Wright DJ, Zhang H (2002) Selection of in vitro mutants of pyrazinamide-resistant mycobacterium tuberculosis. Int J Antimicrob Agents 20:275-281
12. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS (1997) Role of the major antigen of mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420-1422
13. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K (2002) Evaluation of a nutrient starvation model of mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43:717-731
14. Birnbaum M, Koch R, Brendecke F (1891) Prof. Koch's method to cure tuberculosis popularly treated. H.E. Haferkorn, Milwaukee
15. Boshoff HI, Mizrahi V (2000) Expression of mycobacterium smegmatis pyrazinamidase in mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. J Bacteriol 182:5479-5485
16. Brennan PJ, Nikaido H (1995) The envelope of mycobacteria. Annu Rev Biochem 64:29-63
17. Buchmeier NA, Newton GL, Koledin T, Fahey RC (2003) Association of mycothiol with protection of mycobacterium tuberculosis from toxic oxidants and antibiotics. Mol Microbiol 47:1723-1732
18. Burian J, Ramon-Garcia S, Sweet G, Gomez-Velasco A, Av-Gay Y, Thompson CJ (2012) The mycobacterial transcriptional regulator whiB7 gene links redox homeostasis and intrinsic antibiotic resistance. J Biol Chem 287:299-310
19. Buriankova K, Doucet-Populaire F, Dorson O, Gondran A, Ghnassia JC, Weiser J, Pernodet JL (2004) Molecular basis of intrinsic macrolide resistance in the mycobacterium tuberculosis complex. Antimicrob Agents Chemother 48:143-150
20. Campbell PJ, Morlock GP, Sikes RD et al (2011) Molecular detection of mutations associated with first-and second-line drug resistance compared with conventional drug susceptibility testing of mycobacterium tuberculosis. Antimicrob Agents Chemother 55:2032-2041
21. Chambers HF, Moreau D, Yajko D et al (1995) Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrob Agents Chemother 39:2620-2624
22. Chao J, Wong D, Zheng X, Poirier V, Bach H, Hmama Z, Av-Gay Y (2010) Protein kinase and phosphatase signaling in mycobacterium tuberculosis physiology and pathogenesis. Biochim Biophys Acta 1804:620-627
23. Chen W, Biswas T, Porter VR, Tsodikov OV, Garneau-Tsodikova S (2011) Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB. Proc Natl Acad Sci USA 108:9804-9808
24. Colangeli R, Haq A, Arcus VL et al (2009) The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc Natl Acad Sci USA 106:4414-4418
25. Colangeli R, Helb D, Sridharan S et al (2005) The mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol Microbiol 55:1829-1840
26. Colangeli R, Helb D, Vilcheze C et al (2007) Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M tuberculosis. PLoS Pathog 3:e87
27. Comas I, Borrell S, Roetzer A et al (2012) Whole-genome sequencing of rifampicin-resistant mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 44:106-110
28. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C (2003) The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009-1021
29. D'Costa VM, King CE, Kalan L et al (2011) Antibiotic resistance is ancient. Nature 477:457-461
30. D'Costa VM, McGrann KM, Hughes DW, Wright GD (2006) Sampling the antibiotic resistome. Science 311:374-377
31. da Silva PE, Von Groll A, Martin A, Palomino JC (2011) Efflux as a mechanism for drug resistance in mycobacterium tuberculosis. FEMS Immunol Med Microbiol 63:1-9
32. Danilchanka O, Pavlenok M, Niederweis M (2008) Role of porins for uptake of antibiotics by mycobacterium smegmatis. Antimicrobial Agents Chemother 52:3127-3134
33. Demple B (2005) The Nexus of oxidative stress responses and antibiotic resistance mechanisms in escherichia coli and Salmonella. In: White DG, Alekshun MN, McDermott PF, Levy SB (eds) Frontiers in antimicrobial resistance: A tribute to Stuart B. Levy. American Society for Microbiology, Washington, DC, pp 191-197
34. Dhar N, McKinney JD (2010) Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice. Proc National Acad Sci USA 107:12275-12280
35. Dorman SE, Chaisson RE (2007) From magic bullets back to the magic mountain: The rise of extensively drug-resistant tuberculosis. Nat Med 13:295-298
36. Duncan K, Barry CE 3rd (2004) Prospects for new antitubercular drugs. Curr Opin Microbiol 7:460-465
37. Engstrom A, Perskvist N, Werngren J, Hoffner SE, Jureen P (2011) Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in mycobacterium tuberculosis. J Antimicrob Chemother 66:1247-1254
38. Ferber D (2005) Biochemistry. Protein that mimics DNA helps tuberculosis bacteria resist antibiotics. Science 308:1393
39. Flores AR, Parsons LM, Pavelka MS Jr (2005) Genetic analysis of the beta-lactamases of mycobacterium tuberculosis and mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology 151:521-532
40. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ (2006) The competitive cost of antibiotic resistance in mycobacterium tuberculosis. Science 312:1944-1946
41. Gao LY, Laval F, Lawson EH et al (2003) Requirement for kasB in mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: Implications for therapy. Mol Microbiol 49:1547-1563
42. Garton NJ, Waddell SJ, Sherratt AL et al (2008) Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS medicine 5:e75
43. Gengenbacher M, Kaufmann SH (2012) Mycobacterium tuberculosis: Success through dormancy. FEMS Microbiol Rev 36:514-532
44. Gillespie SH, Billington OJ, Breathnach A, McHugh TD (2002) Multiple drug-resistant mycobacterium tuberculosis: Evidence for changing fitness following passage through human hosts. Microbial Drug Resist 8:273-279
45. Gomez JE, McKinney JD (2004) M tuberculosis persistence, latency, and drug tolerance. Tuberculosis 84:29-44
46. Han JS, Lee JJ, Anandan T et al (2010) Characterization of a chromosomal toxin-antitoxin, Rv1102c-Rv1103c system in mycobacterium tuberculosis. Biochemical Biophys Res Commun 400:293-298
47. Hansen S, Lewis K, Vulic M (2008) Role of global regulators and nucleotide metabolism in antibiotic tolerance in escherichia coli. Antimicrobial Agents Chemother 52:2718-2726
48. Hegde SS, Vetting MW, Roderick SL, Mitchenall LA, Maxwell A, Takiff HE, Blanchard JS (2005) A fluoroquinolone resistance protein from mycobacterium tuberculosis that mimics DNA. Science 308:1480-1483
49. Hengge-Aronis R (2002) Signal transduction and regulatory mechanisms involved in control of the sigma(S) (RpoS) subunit of RNA polymerase. Microbiol Mol Biol Rev: MMBR 66:373-395
50. Hoffmann C, Leis A, Niederweis M, Plitzko JM, Engelhardt H (2008) Disclosure of the mycobacterial outer membrane: Cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci USA 105:3963-3967
51. Huang WL, Chi TL, Wu MH, Jou R (2011) Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant mycobacterium tuberculosis. J Clin Microbiol 49:2502-2508
52. Hugonnet JE, Blanchard JS (2007) Irreversible inhibition of the mycobacterium tuberculosis beta-lactamase by clavulanate. Biochemistry 46:11998-12004
53. Ito K, Yamamoto K, Kawanishi S (1992) Manganese-mediated oxidative damage of cellular and isolated DNA by isoniazid and related hydrazines: Non-Fenton-type hydroxyl radical formation. Biochemistry 31:11606-11613
54. Jarlier V, Gutmann L, Nikaido H (1991) Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in mycobacterium chelonae. Antimicrob Agents Chemother 35:1937-1939
55. Johansen SK, Maus CE, Plikaytis BB, Douthwaite S (2006) Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2'-O-methylations in 16S and 23S rRNAs. Mol Cell 23:173-182
56. Kasik JE (1979) Mycobacterial Beta-Lactamases. In: Hamilton-Miller JMT, Smith JT (eds) Beta-Lactamases. Academic Press, London, p 500
57. Kasik JE, Peacham L (1968) Properties of beta-lactamases produced by three species of mycobacteria. Biochem J 107:675-682
58. Keiler KC (2008) Biology of trans-translation. Annual Rev Microbiol 62:133-151
59. Keren I, Minami S, Rubin E, Lewis K (2011) Characterization and transcriptome analysis of mycobacterium tuberculosis persisters. mBio 2:e00100-00111
60. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in escherichia coli. J Bacteriol 186:8172-8180
61. Kohanski MA, DePristo MA, Collins JJ (2010a) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37:311-320
62. Kohanski MA, Dwyer DJ, Collins JJ (2010b) How antibiotics kill bacteria: From targets to networks. Nat Rev Microbiol 8:423-435
63. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810
64. Lewis K (2008) Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322:107-131
65. Li Y, Zhang Y (2007) PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in escherichia coli. Antimicrobial Agents Chemother 51:2092-2099
66. Liu J, Nikaido H (1999) A mutant of mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates. Proc Natl Acad Sci U S A 96:4011-4016
67. Liu J, Rosenberg EY, Nikaido H (1995) Fluidity of the lipid domain of cell wall from mycobacterium chelonae. Proc Natl Acad Sci USA 92:11254-11258
68. Madsen CT, Jakobsen L, Buriankova K, Doucet-Populaire F, Pernodet JL, Douthwaite S (2005) Methyltransferase Erm(37) slips on rRNA to confer atypical resistance in mycobacterium tuberculosis. J Biol Chem 280:38942-38947
69. Maus CE, Plikaytis BB, Shinnick TM (2005) Mutation of tlyA confers capreomycin resistance in mycobacterium tuberculosis. Antimicrobial Agents Chemother 49:571-577
70. McCune RM Jr, McDermott W, Tompsett R (1956) The fate of mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med 104:763-802
71. McCune RM Jr, Tompsett R (1956) Fate of mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med 104:737-762
72. McKenzie JL, Robson J, Berney M et al (2012) A VapBC toxin-antitoxin module is a posttranscriptional regulator of metabolic flux in mycobacteria. J Bacteriol 194:2189-2204
73. Michele TM, Ko C, Bishai WR (1999) Exposure to antibiotics induces expression of the mycobacterium tuberculosis sigF gene: Implications for chemotherapy against mycobacterial persistors. Antimicrobial Agents Chemother 43:218-225
74. Montero C, Mateu G, Rodriguez R, Takiff H (2001) Intrinsic resistance of mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob Agents Chemother 45:3387-3392
75. Morais Cabral JH, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington RC (1997) Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388:903-906
76. Morris RP, Nguyen L, Gatfield J et al (2005) Ancestral antibiotic resistance in mycobacterium tuberculosis. Proc Natl Acad Sci USA 102:12200-12205
77. Myers A (1963) Can tuberculosis be eradicated? Chest 43:327-329
78. Nampoothiri KM, Rubex R, Patel AK, Narayanan SS, Krishna S, Das SM, Pandey A (2008) Molecular cloning, overexpression and biochemical characterization of hypothetical betalactamases of mycobacterium tuberculosis H37Rv. J Appl Microbiol 105:59-67
79. Nash KA (2003) Intrinsic macrolide resistance in mycobacterium smegmatis is conferred by a novel erm gene, erm(38). Antimicrob Agents Chemother 47:3053-3060
80. Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr (2005) Molecular basis of intrinsic macrolide resistance in clinical isolates of mycobacterium fortuitum. J Antimicrob Chemother 55:170-177
81. Nguyen L (2012) Targeting antibiotic resistance mechanisms in mycobacterium tuberculosis: Recharging the old magic bullets. Expert Rev Anti Infect Ther 10:963-965
82. Nguyen L, Chinnapapagari S, Thompson CJ (2005) FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of mycobacterium smegmatis. J Bacteriol 187:6603-6611
83. Nguyen L, Pieters J (2009) Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: Challenges in tuberculosis drug development. Ann Rev Pharmacol Toxicol 49:427-453
84. Niebisch A, Kabus A, Schultz C, Weil B, Bott M (2006) Corynebacterial protein kinase G controls 2-oxoglutarate dehydrogenase activity via the phosphorylation status of the OdhI protein. J Biol Chem 281:12300-12307
85. Niederweis M (2003) Mycobacterial porins-new channel proteins in unique outer membranes. Mol Microbiol 49:1167-1177
86. Nikaido H (1994) Prevention of drug access to bacterial targets: Permeability barriers and active efflux. Science 264:382-388
87. Nishino K, Yamaguchi A (2001) Analysis of a complete library of putative drug transporter genes in escherichia coli. J Bacteriol 183:5803-5812
88. Nott TJ, Kelly G, Stach L, et al (2009) An intramolecular switch regulates phosphoindependent FHA domain interactions in mycobacterium tuberculosis. Science Signal 2:ra12
89. Ormerod LP (2005) Multidrug-resistant tuberculosis (MDR-TB): Epidemiology, prevention and treatment. Br Med Bull 73-74:17-24
90. Philalay JS, Palermo CO, Hauge KA, Rustad TR, Cangelosi GA (2004) Genes required for intrinsic multidrug resistance in mycobacterium avium. Antimicrob Agents Chemother 48:3412-3418
91. Quinting B, Reyrat JM, Monnaie D et al (1997) Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics. FEBS Lett 406:275-278
92. Rawat M, Newton GL, Ko M, Martinez GJ, Fahey RC, Av-Gay Y (2002) Mycothiol-deficient mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics. Antimicrob Agents Chemother 46:3348-3355
93. Reynolds MG (2000) Compensatory evolution in rifampin-resistant escherichia coli. Genetics 156:1471-1481
94. Saguy M, Gillet R, Skorski P, Hermann-Le Denmat S, Felden B (2007) Ribosomal protein S1 influences trans-translation in vitro and in vivo. Nucleic Acids Res 35:2368-2376
95. Sala C, Haouz A, Saul FA, Miras I, Rosenkrands I, Alzari PM, Cole ST (2009) Genome-wide regulon and crystal structure of BlaI (Rv1846c) from mycobacterium tuberculosis. Mol Microbiol 71:1102-1116
96. Scanga CA, Mohan VP, Joseph H, Yu K, Chan J, Flynn JL (1999) Reactivation of latent tuberculosis: Variations on the cornell murine model. Infect Immun 67:4531-4538
97. Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y (1997) Characterization of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis. Antimicrobial Agents Chemother 41:540-543
98. Scorpio A, Zhang Y (1996) Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2:662-667
99. Senaratne RH, Mobasheri H, Papavinasasundaram KG, Jenner P, Lea EJ, Draper P (1998) Expression of a gene for a porin-like protein of the OmpA family from mycobacterium tuberculosis H37Rv. J Bacteriol 180:3541-3547
100. Sergeev R, Colijn C, Murray M, Cohen T (2012) Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis. Sci Transl Med 4:135ra167
101. Sharp JD, Cruz JW, Raman S, Inouye M, Husson RN, Woychik NA (2012) Growth and translation inhibition through sequence-specific RNA binding by mycobacterium tuberculosis VapC toxin. J Biol Chem 287:12835-12847
102. Sherman DR, Mdluli K, Hickey MJ, Arain TM, Morris SL, Barry CE 3rd, Stover CK (1996) Compensatory ahpC gene expression in isoniazid-resistant mycobacterium tuberculosis. Science 272:1641-1643
103. Shi L, Sohaskey CD, Kana BD, Dawes S, North RJ, Mizrahi V, Gennaro ML (2005) Changes in energy metabolism of mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci USA 102:15629-15634
104. Shi W, Zhang X, Jiang X et al (2011) Pyrazinamide inhibits trans-translation in mycobacterium tuberculosis. Science 333:1630-1632
105. Shi W, Zhang Y (2010) PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in mycobacterium tuberculosis. J Antimicrob Chemother 65:1237-1242
106. Shiba T, Tsutsumi K, Yano H et al (1997) Inorganic polyphosphate and the induction of rpoS expression. Proc Natl Acad Sci USA 94:11210-11215
107. Singh A, Gupta R, Vishwakarma RA, Narayanan PR, Paramasivan CN, Ramanathan VD, Tyagi AK (2005) Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol 187:4173-4186
108. Singh A, Jain S, Gupta S, Das T, Tyagi AK (2003) mymA operon of mycobacterium tuberculosis: Its regulation and importance in the cell envelope. FEMS Microbiol Lett 227:53-63
109. Siroy A, Mailaender C, Harder D et al (2008) Rv1698 of mycobacterium tuberculosis represents a new class of channel-forming outer membrane proteins. J Biol Chem 283:17827-17837
110. Stephan J, Mailaender C, Etienne G, Daffe M, Niederweis M (2004) Multidrug resistance of a porin deletion mutant of mycobacterium smegmatis. Antimicrob Agents Chemother 48:4163-4170
111. Thayil SM, Morrison N, Schechter N, Rubin H, Karakousis PC (2011) The role of the novel exopolyphosphatase MT0516 in mycobacterium tuberculosis drug tolerance and persistence. PloS one 6:e28076
112. Tian J, Bryk R, Itoh M, Suematsu M, Nathan C (2005) Variant tricarboxylic acid cycle in mycobacterium tuberculosis: Identification of alpha-ketoglutarate decarboxylase. Proc Natl Acad Sci USA 102:10670-10675
113. Tremblay LW, Fan F, Blanchard JS (2010) Biochemical and structural characterization of mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem. Biochemistry 49:3766-3773
114. Udwadia ZF (2012) MDR, XDR, TDR tuberculosis: Ominous progression. Thorax 67:286-288
115. Vetting M, Roderick SL, Hegde S, Magnet S, Blanchard JS (2003) What can structure tell us about in vivo function? The case of aminoglycoside-resistance genes. Biochem Soc Trans 31:520-522
116. Vilcheze C, Av-Gay Y, Attarian R et al (2008) Mycothiol biosynthesis is essential for ethionamide susceptibility in mycobacterium tuberculosis. Molec Microbiol 69:1316-1329
117. Viveirosa M, Martins M, Rodrigues L, Machado D, Coutoa I, Ainsad J, Amaral L (2012) Inhibitors of mycobacterial efflux pumps as potential boosters for TB drugs. Expert Rev Anti Infect Ther 10:983-998
118. Voladri RK, Lakey DL, Hennigan SH, Menzies BE, Edwards KM, Kernodle DS (1998) Recombinant expression and characterization of the major beta-lactamase of mycobacterium tuberculosis. Antimicrob Agents Chemother 42:1375-1381
119. Walburger A, Koul A, Ferrari G et al (2004) Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304:1800-1804
120. Wallis RS, Patil S, Cheon SH et al (1999) Drug tolerance in mycobacterium tuberculosis. Antimicrobial Agents Chemother 43:2600-2606
121. Wang F, Cassidy C, Sacchettini JC (2006) Crystal structure and activity studies of the mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics. Antimicrob Agents Chemother 50:2762-2771
122. Wang JY, Burger RM, Drlica K (1998) Role of superoxide in catalase-peroxidase-mediated isoniazid action against mycobacteria. Antimicrobial Agents Chemother 42:709-711
123. Wang X, Mitra N, Secundino I et al (2012) Specific inactivation of two immunomodulatory SIGLEC genes during human evolution. Proc Natl Acad Sci USA 109:9935-9940
124. Watt B, Edwards JR, Rayner A, Grindey AJ, Harris G (1992) In vitro activity of meropenem and imipenem against mycobacteria: Development of a daily antibiotic dosing schedule. Tuber Lung Dis 73:134-136
125. Wayne LG, Hayes LG (1996) An in vitro model for sequential study of shiftdown of mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64:2062-2069
126. Wei J, Dahl JL, Moulder JW, Roberts EA, O'Gaora P, Young DB, Friedman RL (2000) Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages. J Bacteriol 182:377-384
127. Wolff KA, Nguyen HT, Cartabuke RH, Singh A, Ogwang S, Nguyen L (2009) Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria. Antimicrobial Agents Chemother 53:3515-3519
128. Wower IK, Zwieb CW, Guven SA, Wower J (2000) Binding and cross-linking of tmRNA to ribosomal protein S1, on and off the escherichia coli ribosome. EMBO J 19:6612-6621
129. Xie Z, Siddiqi N, Rubin EJ (2005) Differential antibiotic susceptibilities of starved mycobacterium tuberculosis isolates. Antimicrobial Agents Chemother 49:4778-4780
130. Zaunbrecher MA, Sikes RD Jr, Metchock B, Shinnick TM, Posey JE (2009) Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in mycobacterium tuberculosis. Proc Natl Acad Sci USA 106:20004-20009
131. Zhang Y (2012) Drug resistant and persistent tuberculosis: Mechanisms and drug development. In: Dougherty TJ, Pucci MJ (ed) Antibiotic discovery and development. Springer Science ? Business Media, pp 719-746
132. Zhang Y, Dhandayuthapani S, Deretic V (1996) Molecular basis for the exquisite sensitivity of mycobacterium tuberculosis to isoniazid. Proc Natl Acad Sci USA 93:13212-13216
133. Zhang Y, Heym B, Allen B, Young D, Cole S (1992) The catalase-peroxidase gene and isoniazid resistance of mycobacterium tuberculosis. Nature 358:591-593
134. Zuber B, Chami M, Houssin C, Dubochet J, Griffiths G, Daffe M (2008) Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J Bacteriol 190:5672-5680